Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

CME Group Inc. CME

Financial — Financial Data & Stock Exchanges
S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index ,
Growth Flags show if company had growth for consecutive years ,
Insider Buys alert about insiders buying in the last 12 month

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total buys
0.59
Total sells
30.01
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — 1 — — 1 — — 1 — — —
Sell — 2 1 — 3 3 — 2 — — — 2
Insider Ownership
1.68%

Capital & Financial Ratios

Market Cap
96,010.00
Revenue
6,772.60
Net Income
4,287.00
Free Cash Flow
4,212.70
Net Debt
1,148.60
Current Ratio
1.02
Debt/Equity
0.13
P/E ratio
23.23
P/S ratio
14.70
P/B ratio
3.75
Past 5Y EPS Growth
10.36%
This Y EPS Growth
9.37%
Next Y EPS Growth
5.50%
Next 5Y EPS Growth
7.37%
in millions of $

Dividends

Payout Ratio
1.06
Annual Dividend Rate
4.40
Annual Dividend Yield
4.58%
total individual payouts
2028 ‡‡‡‡‡
2027 ‡‡‡‡‡
2026 11.89
—
—
—
2025 9.72
—
—
—
—
2024 4.60
—
—
—
—
—
2023 4.40
—
—
—
—
—
2022 4.00
—
—
—
—
—
2021 3.60
—
—
—
—
—
2020 3.40
—
—
—
—
—
2019 3.00
—
—
—
—
—
2018 2.80
—
—
—
—
—
2017 2.64
—
—
—
—
—
2016 2.40
—
—
—
—
—
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 3,023.70 3,005.60 4,541.90 2,275.60
Receivables 535.60 573.10 639.20 753.10
Inventory — — — —
Other 91,330.90 99,454.80 160,178.20 158,602.40
94,890.20 103,033.50 165,359.30 161,631.10
2023 2024 2025 Q'26
Payables 90.60 79.90 71.80 68.00
ST’ Debt — — — —
Other 93,326.30 101,484.20 160,224.90 158,649.30
93,416.90 102,313.90 160,296.70 158,717.30
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 1,880.10 1,706.20 — —
—
’25 1,642.30 1,692.00 1,537.60 1,648.70
6,520.60
’24 1,487.90 1,532.50 1,584.40 1,525.30
6,130.10
’23 1,441.60 1,360.20 1,337.80 1,439.30
5,578.90
’22 1,346.60 1,237.20 1,227.80 1,207.80
5,019.40
’21 1,253.30 1,179.20 1,109.90 1,147.30
4,689.70
’20 1,522.10 1,182.30 1,080.70 1,098.50
4,883.60
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 1,259.90 947.10 — —
—
’25 1,116.60 1,058.50 968.10 1,133.90
4,277.10
’24 892.70 776.90 1,003.00 1,017.90
3,690.50
’23 902.40 650.40 856.70 1,044.30
3,453.80
’22 799.10 617.60 657.80 981.50
3,056.00
’21 602.70 499.80 631.60 668.30
2,402.40
’20 757.10 986.80 311.40 660.30
2,715.60
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 1,238.10 923.50 — —
—
’25 1,102.40 1,040.10 949.70 1,101.40
4,193.60
’24 872.90 758.70 973.20 991.70
3,596.50
’23 887.20 629.90 836.80 1,023.50
3,377.40
’22 775.70 599.70 633.80 957.10
2,966.30
’21 574.20 460.10 599.90 680.30
2,314.50
’20 714.30 950.40 263.10 590.30
2,518.10
in millions of $

EPS

Mar Jun Sep Dec Year
’26 3.18 2.88 — —
—
’25 2.62 2.81 2.49 3.24
11.16
’24 2.35 2.42 2.50 2.40
9.67
’23 2.43 2.14 2.06 2.24
8.86
’22 1.95 1.82 1.87 1.75
7.40
’21 1.60 1.42 2.58 1.71
7.29
’20 2.14 1.40 1.15 1.18
5.87

Target Price Range

High
‡‡‡‡‡
‡‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡‡

Recommendation Rating

2.5
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 166.58 166.55 190.70 224.62 — — —
Low Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 256.94 223.80 249.02 290.79 — — —
High Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3,460 3,565 3,760 3,875 — — —
Employees
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.45 1.56 1.63 1.68 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5,019.40 5,578.90 6,130.10 6,520.60 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ 100.00% 100.00% 100.00% 100.00% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3,490.30 4,153.60 4,541.40 5,330.50 ‡‡‡‡‡ — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 69.54% 74.45% 74.08% 81.75% ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,691.00 3,226.20 3,525.80 4,072.20 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 362.60 352.60 336.80 330.90 — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 13.99 15.54 17.06 18.13 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡ 7.41 8.87 9.69 11.18 ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 8.52 9.62 10.27 11.89 — — —
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.25) (0.21) (0.26) (0.23) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 8.27 9.41 10.01 11.66 — — —
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 74.93 74.47 73.70 79.88 ‡‡‡‡‡ — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 358.71 359.02 359.39 359.65 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 22.80 23.59 23.97 24.43 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 12.07 13.46 13.61 15.06 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.25 2.81 3.15 3.42 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 12.21 13.55 13.57 14.90 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 20.66 22.38 23.13 23.17 — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3,056.00 3,453.80 3,690.50 4,277.10 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (89.70) (76.40) (94.00) (83.50) ‡‡‡‡‡ ‡‡‡‡‡ —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,966.30 3,377.40 3,596.50 4,193.60 ‡‡‡‡‡ — —
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,390.80 1,473.30 719.60 5,062.60 — — —
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3,496.40 3,425.40 2,678.20 3,422.30 — — —
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 680.30 401.70 (327.40) (1,119.60) — — —
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 26,878.70 26,737.90 26,486.90 28,728.20 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.43% 2.10% 2.61% 2.39% ‡‡‡‡‡ — —
ROA
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 6.84% 7.91% 9.39% 9.57% — — —
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9.79% 11.88% 13.08% 14.56% ‡‡‡‡‡ — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

CME Group Inc. stands as a resilient powerhouse in derivatives trading, thriving amid macroeconomic turbulence with revenue surging from $3.6 billion in 2016 to $6.13 billion in 2024—a 6% CAGR even through the pandemic. Its transaction-based model scales with volatility from interest rates, geopolitics, and commodities, delivering 100% gross margins, EBT peaks near 81%, and ROE climbing to 13.1%. Free cash flow per share doubled to $10.01, funding buybacks and a 25+ year dividend streak, while a pristine balance sheet shifted to net cash of $1.12 billion by 2025.

Stock performance has mirrored this strength, with highs expanding 134% since 2016 and downside volatility shrinking, decoupling from market selloffs as a prime “volatility beneficiary.” Key catalysts like Bitcoin futures, the NEX acquisition, Fed rate hikes, and global tensions have driven record volumes, keeping multiples reasonable (24x P/E, 23x EV/FCF) despite premium pricing for its moat.

Projections signal continued momentum: EPS to $11.42 by 2026 (18% growth), revenue at $6.90 billion, fueled by central bank divergence and commodity supercycles. While net insider selling persists, selective buys and modest 3-12% upside targets suggest constructive potential for patient investors eyeing mid-teens returns—yet vulnerable to a soft landing.

Read full commentary →

CME Group Inc. (CME) Latest News

News by impact score

Fine-tune

18 Sep

4 , 8:19 PM
CME Group launches new loan futures while metals trading volumes reach record highs. New loan futures launch expands CME product suite and trading activity.

16 Sep

4 , 11:38 AM
Higher interest rates carry elevated stakes for CME Group because of their direct effect on volumes in interest rate futures and options trading. Potential rate hikes can substantially boost or alter trading volumes in CME's key interest rate products.

15 Sep

4 , 2:00 PM
CME Group launches Liquid Leveraged Loan Index Futures to expand its credit ecosystem. New futures product launch expands credit offerings and may drive volume growth.

14 Sep

3 , 11:04 AM
CME Group 100-ounce silver futures attract significant demand in the first weekend of 24/7 trading. New 24/7 silver futures trading draws demand that may boost CME volumes without altering core trajectory.

3 , 9:00 AM
Webull adds CME Nano Futures to its offerings, giving retail investors access to smaller equity index contracts. Expanded retail access via Webull may lift trading volumes in CME nano products without altering core business trajectory.

13 Sep

4 www.thestreet.com, 12:03 PM
CME Group faces an unusual position amid a $93 trillion trading boom. A $93 trillion trading boom signals major volume growth and revenue potential for CME exchange operations.

9 Sep

3 , 10:50 AM
NFL season launch projected to drive record sports betting volumes and prediction market growth despite AGA opposition, increasing trading activity and revenue potential for CME Group. Prediction market expansion tied to NFL betting may boost CME trading volumes but effects remain limited to specific product lines without altering core trajectory.

8 Sep

4 , 7:00 AM
CME Group will enter the European dairy market by transitioning EEX dairy products. Entry into European dairy market constitutes a major strategic expansion for CME Group.

3 247wallst.com, 10:41 AM
Bill Ackman identifies CME Group Inc. as an AI bargain, highlighting its ownership of the New York Stock Exchange as a key factor in his assessment. Bill Ackman's positive view on CME as an AI opportunity could moderately lift investor sentiment without altering core operations.

7 Sep

3 , 7:00 AM
CME Group sets new record for FX open interest. New FX open interest record points to higher trading activity in CME core derivatives segment.

5 Sep

3 , 5:07 PM
CME Group appears fully valued amid Federal Reserve rate cut expectations and launch of new futures contracts that attract investor focus. Fed rate bets and new futures point to moderate effects on CME positioning and sentiment without major trajectory shifts.

3 , 2:11 PM
CME Group achieved record interest in Henry Hub futures while August trading volumes remained strong. Record Henry Hub interest and sustained August volumes indicate higher trading activity that can lift near-term revenue for CME's energy derivatives segment.

2 Sep

3 , 3:11 PM
CME Group set a new open interest record in Henry Hub Natural Gas Futures. Record open interest signals stronger trading volumes in energy futures without indicating broader strategic or financial shifts.

3 , 7:30 AM
CME Group reported second-highest August ADV of 29.7 million contracts. Strong August trading volumes support CME Group's core fee-based revenue but represent routine monthly data.

29 Aug

4 , 8:11 AM
CME Group launches new factor and wind power futures suite to potentially shift its market narrative and product offerings. New futures products in factor and wind power expand CME's contract range and target growing renewable energy trading demand.

4 , 7:51 AM
CME Group launches futures contracts tied to Nvidia AI chips, creating a new trading market for Wall Street participants seeking exposure to semiconductor demand. Nvidia AI chip futures expand CME product lineup and trading volumes in a high-growth sector.

28 Aug

3 videos.coindesk.com, 8:57 AM
Walt Lukken addresses CFTC Innovation Committee efforts to regulate automated trading machines with direct implications for CME Group futures and derivatives markets. CFTC regulatory discussions on machine trading may affect CME compliance requirements and platform operations.

27 Aug

3 www.benzinga.com, 12:12 PM
Kalshi partners with The Weather Company and projects $1.1B in weather trading volume for 2026. Kalshi expansion adds direct competition to CME weather derivatives.

3 , 7:30 AM
CME Group Inc. will launch E-mini Equity Factor Futures on September 21. New product launch expands futures offerings and may lift volumes without major strategic shift.

3 , 2:00 AM
Precious metals markets show signs of potential rebound amid shifting economic conditions, which may boost trading volumes in gold, silver and related futures contracts on CME Group platforms. Potential rebound in precious metals trading volumes could moderately lift CME's derivatives revenue without fundamentally changing its business trajectory.

26 Aug

4 , 7:00 AM
CME Group launches contracts for hedging in the wind energy sector to support renewable energy markets. New wind energy hedging contracts represent a major strategic expansion into renewables that can alter CME's growth trajectory.

3 , 1:10 PM
CME Group launches new U.S. zinc futures contracts to expand metals trading offerings and capture additional market share in commodities derivatives. New zinc futures launch expands CME product range in metals with moderate effect on operations and positioning.

3 , 8:00 AM
CME Group Inc. launches LeagueShares as the first ETF issuer dedicated solely to capturing sports performance. New ETF issuer launch may influence product innovation at CME but remains limited in scope relative to core exchange operations.

25 Aug

3 , 1:34 PM
CME Group Inc. executed the first trade of U.S. Zinc Futures. Launch of zinc futures adds new metals contract with potential to increase trading volumes.

24 Aug

4 247wallst.com, 10:30 AM
Trump signals potential approval for 50x leverage on stocks, prompting divided reactions on Wall Street over market risks and opportunities for exchanges including CME. Higher leverage rules could drive substantial growth in derivatives and futures volumes handled by CME.

4 , 7:30 AM
CME Group advances $500 billion blockchain project to enable 24/7 markets. Blockchain push for continuous trading marks major strategic shift with potential to alter CME infrastructure and market reach.

3 , 4:29 PM
CME Group instruments enable negative beta bets that hedge portfolios against potential AI stock selloffs and associated market volatility. CME hedging products may see increased use and trading activity from AI-related portfolio protection strategies.

3 , 1:45 PM
CME Group reported Q2 earnings within a review of financial exchanges and data stocks performance. Q2 earnings provide moderate insight into CME financial performance without altering long-term trajectory.

21 Aug

4 , 3:11 AM
CME Group is emerging as a key voice in crypto regulation. CME's growing role in crypto regulation discussions signals potential expansion in digital asset markets and derivatives.

3 , 9:11 PM
CME Group challenges prediction markets while its stock faces questions over fair value. Potential move into prediction markets could moderately shift competitive positioning and investor views on CME.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us